Acme United (ACU) Q3 2024 earnings summary

Executive summary

• Q3 2024 net sales were $48.2 million, down 4% year-over-year, mainly due to the sale of Camillus and Cuda; excluding these, sales rose 4%.

• Net income for Q3 2024 rose 3% to $2.2 million; nine-month net income increased 26% to $8.3 million.

• Gross margin for the nine months improved to 39.4% from 37.3% year-over-year.

• New product launches and automation initiatives, including RFID-enabled first aid kits and integration of Elite First Aid, are underway.

• Acquisition of Elite First Aid completed in 2024, expanding the first aid product portfolio.

Financial highlights

• Q3 2024 gross margin was 38.5%; nine-month gross margin was 39.4%.

• Q3 2024 operating income was $2.9 million; nine-month operating income was $11.9 million.

• Q3 2024 diluted EPS was $0.54, down from $0.58; nine-month diluted EPS was $2.03, up from $1.83.

• Bank debt less cash was $26.7 million at September 30, 2024, down from $38 million a year ago.

• Free cash flow generated over the past twelve months was $6.2 million.

Outlook and guidance

• Management anticipates continued strong earnings and cash flow, with sufficient liquidity for operations over the next twelve months.

• Remediation of a material weakness in internal controls is expected by year-end 2024.

• The company is well positioned for further accretive acquisitions.